Doctors successfully reversed a patient’s life-threatening brain condition caused by gastric bypass surgery using a minimally invasive camera-guided procedure that placed a metal stent to reconnect her stomach. According to Gram Research analysis of this case report, the patient’s ammonia levels dropped rapidly, her neurological symptoms disappeared, and she maintained improvement for at least 2 months. This approach may offer a safer alternative to major surgery for patients too weak to undergo traditional reversal.
A 62-year-old woman who had gastric bypass surgery years earlier developed a dangerous brain condition called hyperammonemic encephalopathy, caused by her body struggling to process ammonia properly. Instead of performing major surgery to fix the problem, doctors used a minimally invasive camera-based procedure to place a special metal stent that reconnected her stomach, allowing food to bypass the problematic section. According to Gram Research analysis, this approach rapidly improved her symptoms, lowered her ammonia levels, and helped her gain back healthy weight. This case suggests that endoscopic reversal could be a safer option for patients too weak or sick for traditional surgery.
Key Statistics
A 2026 case report published in VideoGIE documented that endoscopic reversal using a 20-millimeter lumen-apposing metal stent successfully treated hyperammonemic encephalopathy in a 62-year-old woman who was a poor surgical candidate, with complete resolution of neurological symptoms and sustained clinical benefit at 2-month follow-up.
The patient in this case demonstrated rapid clinical improvement following endoscopic reversal, including decreased serum ammonia levels, resolution of encephalopathy symptoms, and progressive weight gain, with the stent remaining patent and complications-free upon removal.
In this 2026 case report, medical management with lactulose and rifaximin provided only partial response to hyperammonemic encephalopathy, whereas endoscopic reversal with metal stent placement achieved complete symptom resolution and sustained improvement.
The Quick Take
- What they studied: Whether doctors could safely reverse a gastric bypass surgery using a camera-guided procedure instead of major surgery to treat a rare but serious brain condition caused by the original weight-loss surgery.
- Who participated: One 62-year-old woman who had undergone gastric bypass surgery previously and developed severe neurological problems including confusion, elevated ammonia levels in her blood, and muscle loss.
- Key finding: The endoscopic procedure with a metal stent successfully reversed the patient’s dangerous condition, with ammonia levels dropping and brain symptoms disappearing within weeks, and benefits lasting at least 2 months after treatment.
- What it means for you: If you or someone you know had gastric bypass surgery and develops confusion, memory problems, or other neurological symptoms, this case shows there may be a less invasive treatment option than major surgery. However, this is based on one patient, so talk to your doctor about whether this approach is right for your situation.
The Research Details
This is a case report, meaning doctors documented the detailed medical story of one patient to show that a new treatment approach worked. The patient was a 62-year-old woman who had undergric bypass surgery years earlier and then developed serious neurological problems including confusion, difficulty thinking clearly, and elevated ammonia levels in her blood—a condition called hyperammonemic encephalopathy.
Instead of performing traditional open surgery to reverse the gastric bypass, the medical team used an endoscopic approach, which means they used a camera inserted through the mouth to guide their work. They placed a special metal stent (a tiny tube) that reconnected the stomach, essentially reversing part of the original surgery. This allowed food to flow more normally through her digestive system, which helped her body process ammonia better.
The doctors monitored the patient closely after the procedure, checking her ammonia levels, neurological symptoms, and weight. They followed up for at least 2 months to confirm the benefits lasted.
This research matters because hyperammonemic encephalopathy after gastric bypass is rare but extremely serious—it can cause permanent brain damage or death. Most patients with this condition are very weak and have lost a lot of muscle, making them poor candidates for major surgery. This case demonstrates that a minimally invasive camera-based approach might be safer for these high-risk patients while still effectively treating the problem.
This is a single case report, which is the lowest level of scientific evidence. It shows that the treatment worked for one patient, but we cannot conclude it will work for everyone. The patient was carefully monitored and the results were well-documented, which strengthens the case. However, more studies with multiple patients are needed to confirm this approach is safe and effective for broader use. The fact that it was published in a peer-reviewed medical journal means other experts reviewed the work before publication.
What the Results Show
The patient underwent an endoscopic procedure where doctors used ultrasound guidance to place a 20-millimeter lumen-apposing metal stent (LAMS) that reconnected her stomach. This essentially created a new pathway for food, bypassing the problematic section created by her original gastric bypass surgery.
Following the procedure, the patient experienced rapid improvement. Her ammonia levels, which had been dangerously elevated, decreased significantly. Her neurological symptoms—including confusion and brain fog—resolved completely. She also began gaining weight in a healthy way, recovering from the severe muscle loss she had experienced.
Imaging studies confirmed that the new connection (called a gastrogastric fistula) remained open and functional. When doctors later removed the stent, there were no complications. At the 2-month follow-up, the patient remained symptom-free and continued to show improvement.
The patient had initially received medical treatment with lactulose and rifaximin (medications commonly used to lower ammonia levels), but these provided only partial improvement. This suggests that the structural problem—the way her digestive system was rerouted—required a structural solution. The successful removal of the stent without complications indicates that the new connection remained stable even after the supporting stent was taken out, suggesting the body had healed properly.
Hyperammonemic encephalopathy after gastric bypass is typically treated with major surgical reversal of the original bypass surgery. This case report suggests that endoscopic reversal using a metal stent may be a viable alternative, particularly for patients who are too weak or medically fragile for traditional surgery. Previous literature has documented this complication as rare but serious; this case adds evidence that minimally invasive approaches deserve consideration.
This is a single case report involving one patient, so we cannot generalize these results to all patients with this condition. Different patients may respond differently based on their age, overall health, and how long they’ve had the problem. The follow-up period was only 2 months, so we don’t know if benefits persist long-term. We also don’t know how often this procedure would work or what percentage of patients might experience complications. More research with multiple patients followed for longer periods is needed before this becomes standard treatment.
The Bottom Line
For patients with hyperammonemic encephalopathy after gastric bypass who are poor surgical candidates: Endoscopic reversal with metal stent placement appears to be a safe and effective option worth discussing with your gastroenterologist and surgeon (Moderate confidence—based on one case). For patients considering gastric bypass surgery: Be aware that this rare but serious complication can occur, though it is uncommon. For healthcare providers: Consider endoscopic reversal as an alternative to major surgery in high-risk patients (Low to Moderate confidence—case report evidence).
This finding is most relevant to: (1) People who had gastric bypass surgery and develop neurological symptoms like confusion or memory problems; (2) Gastroenterologists and surgeons treating post-bariatric surgery complications; (3) Patients who are medically fragile and cannot tolerate major surgery. This does NOT apply to people without gastric bypass surgery or those without symptoms of hyperammonemic encephalopathy.
In this case, the patient showed rapid improvement within days to weeks after the procedure, with complete resolution of brain symptoms and sustained benefit at 2 months. However, individual responses may vary. Recovery and weight gain may continue over several months.
Frequently Asked Questions
Can gastric bypass surgery be reversed without major surgery?
A 2026 case report shows that endoscopic reversal using a metal stent successfully reversed a patient’s gastric bypass complications without major surgery. The patient showed rapid improvement in symptoms and ammonia levels. However, this is based on one patient, so more research is needed.
What is hyperammonemic encephalopathy after gastric bypass?
It’s a rare but serious brain condition that can develop after gastric bypass surgery, causing confusion, memory problems, and difficulty thinking. It occurs when the body cannot properly process ammonia, a toxic waste product. It requires urgent medical treatment.
How common is this complication after weight loss surgery?
Hyperammonemic encephalopathy is rare after gastric bypass surgery, but when it occurs, it’s potentially life-threatening. It’s typically associated with severe weight loss, muscle loss, and bacterial overgrowth in the small intestine. Most gastric bypass patients do not develop this condition.
What symptoms should I watch for if I had gastric bypass surgery?
Watch for confusion, memory problems, difficulty concentrating, unusual tiredness, personality changes, or difficulty with coordination. These could indicate hyperammonemic encephalopathy. Seek immediate medical attention if you develop these symptoms, especially if combined with unexplained weight loss or muscle wasting.
Is endoscopic reversal safer than traditional surgery for this condition?
This case report suggests endoscopic reversal may be safer for high-risk patients who are too weak for major surgery. It’s minimally invasive and showed rapid improvement. However, this is based on one patient, so discuss with your doctor whether it’s appropriate for your specific situation.
Want to Apply This Research?
- If you’ve had gastric bypass surgery, track weekly: (1) Mental clarity and memory (rate 1-10), (2) Any confusion or brain fog episodes, (3) Body weight, (4) Energy levels. Alert your doctor immediately if mental symptoms worsen.
- Set a monthly reminder to discuss any neurological symptoms with your doctor. If you’ve had gastric bypass, keep a symptom log noting any confusion, memory problems, or unusual tiredness. Share this log with your healthcare provider during check-ups.
- Long-term: Schedule annual check-ups with your bariatric surgeon to screen for complications. If symptoms develop, seek immediate medical evaluation. Use the app to track ammonia-related symptoms (confusion, lethargy, difficulty concentrating) and share trends with your medical team.
This article describes a single case report and should not be considered medical advice. Hyperammonemic encephalopathy is a serious medical condition requiring immediate professional evaluation and treatment. If you have had gastric bypass surgery and experience confusion, memory problems, or neurological symptoms, contact your healthcare provider immediately. The endoscopic reversal procedure described is not yet standard treatment and should only be considered under the guidance of experienced bariatric surgeons and gastroenterologists. Individual results may vary significantly from the case presented. Always consult with your medical team before making any decisions about surgical reversal or treatment options.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.